NYSE - Nasdaq Real Time Price USD

PACS Group, Inc. (PACS)

38.50 +6.60 (+20.69%)
As of 12:22:29 PM EDT. Market Open.
Trade PACS on Coinbase
LIVE
PACS Q1 2026 earnings call
Chart Range Bar
Loading chart for PACS
  • Previous Close 31.90
  • Open 38.60
  • Bid --
  • Ask --
  • Day's Range 37.61 - 41.74
  • 52 Week Range 7.50 - 43.08
  • Volume 1,668,000
  • Avg. Volume 828,673
  • Market Cap (intraday) 6.051B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 31.56
  • EPS (TTM) 1.22
  • Earnings Date (est.) Aug 10, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 45.83

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities. The company engages in the acquisition, ownership, and leasing of health care-related properties. PACS Group, Inc. was founded in 2013 and is headquartered in Salt Lake City, Utah.

pacs.com

47,455

Full Time Employees

December 31

Fiscal Year Ends

Performance Overview: PACS

Trailing total returns as of 5/12/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PACS
0.29%
S&P 500 (^GSPC)
7.35%

1-Year Return

PACS
245.60%
S&P 500 (^GSPC)
25.74%

3-Year Return

PACS
67.39%
S&P 500 (^GSPC)
78.19%

5-Year Return

PACS
67.39%
S&P 500 (^GSPC)
80.87%

Earnings Trends: PACS

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized
 

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 1.42B
Earnings 103.48M

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
500M
1B
 

Analyst Insights: PACS

View More

Analyst Price Targets

42.00
45.83 Average
38.50 Current
52.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Latest Rating

Date 3/4/2026
Analyst UBS
Rating Action Maintains
Rating Buy
Price Action Raises
Price Target 42 -> 44
 

Statistics: PACS

View More

Valuation Measures

Annual
As of 5/8/2026
  • Market Cap

    5.28B

  • Enterprise Value

    8.55B

  • Trailing P/E

    27.53

  • Forward P/E

    15.55

  • PEG Ratio (5yr expected)

    1.04

  • Price/Sales (ttm)

    1.00

  • Price/Book (mrq)

    5.58

  • Enterprise Value/Revenue

    1.62

  • Enterprise Value/EBITDA

    23.21

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.49%

  • Return on Assets (ttm)

    4.27%

  • Return on Equity (ttm)

    27.11%

  • Revenue (ttm)

    5.43B

  • Net Income Avi to Common (ttm)

    243.77M

  • Diluted EPS (ttm)

    1.22

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    247.98M

  • Total Debt/Equity (mrq)

    320.07%

  • Levered Free Cash Flow (ttm)

    324.75M

Compare To: PACS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights: PACS

Fair Value

38.50 Current
 

Dividend Score

0 Low
Sector Avg.
100 High
 

Hiring Score

0 Low
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
Sector Avg.
100 High
 

People Also Watch